期刊文献+

IL-1β对人脐静脉内皮细胞蛋白C受体表达的影响 被引量:1

Effect of IL-1β on the Expression of Endothelial Cell Protein C Receptor in Human Umbilical Vein Endothelial Cells
下载PDF
导出
摘要 目的探讨内皮细胞蛋白C受体(EPCR)在人脐静脉内皮细胞(ECV304)上的表达及炎症因子白介素-1β(IL-1β),PPARγ激动剂曲格列酮对其影响.方法采用流式细胞仪检测ECV304中EPCR的表达;实时定量PCR技术(Real-Time PCR)检测IL-1β作用后ECV304细胞EPCR mRNA表达;曲格列酮和IL-1β共同作用于ECV304细胞,实时定量PCR技术检测EPCR mRNA表达.结果 EPCR在ECV304中有很高表达,IL-1β下调ECV304细胞EPCR的表达,而曲格列酮可以明显改善IL-1β对EPCR的抑制.结论 ECV304中EPCR的表达可受到炎症因子IL-1β的影响,曲格列酮对上述影响有一定的拮抗作用,对ECV304损伤有保护作用. Objective To investigate the effect of IL-1β on Endothelial cell protein C receptor(EPCR) expression in umbilical vein endothelial cells.Methods EPCR expression was assessed by flow cytometry in umbilical vein endothelial cells.The effects of IL-1β and troiglitazone were measured by Real-Time PCR. Results Umbilical vein endothelial cells have a high expression of EPCR.IL-1β reduce EPCR expression.And troglitazone could significantly improve the inhibition.Conclusion We observed EPCR expression in umbilical vein endothelial cells in vitro.Some factors such as IL-1β can impact on EPCR.However,troglitazone had protective effects of EPCR on injured cells.
出处 《中国血液流变学杂志》 CAS 2013年第1期24-26,34,共4页 Chinese Journal of Hemorheology
关键词 内皮细胞蛋白C受体 IL-1Β 曲格列酮 endothelial cell protein C receptor(EPCR) IL-1 β troglitazone
  • 相关文献

参考文献6

二级参考文献55

  • 1杨映波,王正国,朱佩芳,刘怀琼,周蓉.循环内皮细胞的基本形态学特性研究[J].中国病理生理杂志,1994,10(4):349-353. 被引量:15
  • 2李毅贤,李春盛.内皮细胞损伤与器官功能不全的关系[J].中国急救医学,2006,26(1):22-25. 被引量:9
  • 3章志丹,穆恩,马晓春.急性肺损伤大鼠血管内皮细胞损伤的研究[J].中国实用外科杂志,2007,27(4):310-312. 被引量:3
  • 4Marcshall JC,Sweeney D.Microbial infection and the septic response in critical surgical illness:sepsis,not infection,determines outcome[J].Arch Surg,1990,125:17-23.
  • 5Roumen RMH,Redl H,Schlag G,et al.Inflammatory mediators in re-lation to the development of multiple organ failure in patients after severe blunt trauma[J].Crit Care Med,1995,23:474-480.
  • 6Hladovec J,Rossman P.Circulating endothelial cells isolated together with platelet and the experimental modification of their counts in rats[J].Thromb Res,1973,3:665.
  • 7Reinhart K,Bayer O,Brunkhorst F,et al.Markers of endothelial damage in organ dysfunction and sepsis[J].Crit Care Med,2002,30 (5):302.
  • 8Loomans CJ,Dekoning EJ,Staal FJ,et al.Endothelial progenitor cell dysfunction in type-1 diabetes:another consequence of oxidative stress[J].Antioxid Redox Signal,2005,7 (11-12):1468.
  • 9Goon PK,Lip GY,Boos CJ,et al.Circulating endothelial cells,endothelial progenitor cells and endothelial microparticles in cancer[J].Neoplasia,2006,8 (2):79.
  • 10Anderson TJ.Assessment and treatment of endothelium dysfunction in humans[J].J Am Coll Cardiol,1999,34:631-638.

共引文献75

同被引文献9

  • 1丁梦杰,张明智.外周T细胞淋巴瘤治疗进展[J].中国实用医刊,2010,37(9):58-60. 被引量:2
  • 2MOSNIER L O, GRIFFIN J H. Protein C anticoagulant a- ctivity in relationto anti inflammatory and anti-apoptotie ac- tivities[ J ]. Front Biosci, 2006,11 ( 16):2 381 --2 399.
  • 3FEMANDES A F, ZHOU J, ZHANG X, et al. Oxidative in- activation of the proteasome in retinal pigment epithelial cell:A potential link between oxidative stress and upregula- tion ofIL-8 [J]. J Biol Chem,2008,28 (3):20 745--20 753.
  • 4RILEY K. FDA approves first drug for treatment of perip - heral T-cell Lymphoma [J]. Mol Cell Pharmacol,2009,1 (4): 230-232.
  • 5OBRIEN L A, GUPTA A, GRINNELL B W.Activated pro- tein C and sepsis [J]. Frontiers in Bioscience,2006,11 ( 1 ):676--695.
  • 6MYLES T, NISHIMURA T, YUN T H, et al. Thrombin acti- vatable ibrinolysis inhibitor, a potential regulator of vascu- lar inflammation [J]. J Biol Chem, 2003 , 278 ( 51 ) : 51 059--51 067.
  • 7ISHIDA Y,TAKAYASU T, KIMURA A,et al. Gene ex- pression of cytokines and growth factors in the lung after paraquat administration in mice [J]. Leg Med,2006,8 (12):102-- 109.
  • 8卢中秋,贺晓艳,洪广亮,何飞,梁欢,邱俏檬,李景荣.百草枯中毒大鼠肺组织血栓调节蛋白和内皮细胞蛋白C受体表达的变化及二巯丙磺钠的作用[J].中华劳动卫生职业病杂志,2009,27(8):453-456. 被引量:5
  • 9李敬,王岚,王璞.川芎嗪治疗百草枯中毒急性肺损伤的疗效分析[J].河北医药,2011,33(15):2269-2270. 被引量:7

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部